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Abstract
Background and Aim The incidence of esophageal ade-
nocarcinoma has increased over the last 30 years, espe-
cially in non-Hispanic whites (nHw). Recent work
indicates an increase in Hispanic Americans (HA). It is
important to understand the effect of ethnicity on cancer
occurrence over a prolonged interval.
Methods We searched the New Mexico Tumor Registry
for all cases of esophageal cancer from 1 January 1973 to
31 December 2002. Inclusion criteria were histologic
diagnosis of adenocarcinoma or squamous cell carcinoma,
ethnicity and gender. Incidence rates for both were com-
pared among ethnic groups in 5-year intervals.
Results Nine hundred eighty-eight patients met the cri-
teria. Esophageal adenocarcinoma incidence rates/100,000
population increased signiﬁcantly over 30 years; 1973–
1977, 0.4 cases; 1978–1982, 0.4 cases; 1983–1987, 0.6
cases; 1988–1992, 1.2 cases, 1993–1997, 1.6 cases and
1998–2002, 2.2 cases; P\0.001. Squamous cell carci-
noma incidence rates remained unchanged during the
interval. In nHw and HA, adenocarcinoma incidence rates
increased signiﬁcantly during the study period. In all
minority groups, squamous cell carcinoma remained the
major type.
Conclusions Esophageal adenocarcinoma incidence
among nHw and HA increased from 1973 to 2002 in New
Mexico. Squamous cell carcinoma remains predominant in
minorities. Ethnicity may inﬂuence the histology or indicate
an increased risk for certain types of esophageal cancer.
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Introduction
Esophageal cancer is the ninth leading cause of cancer-
related death in the US and is expected to result in 14,000
fatalities in 2008 [1]. Approximately, 75% of patients with
esophageal cancer expire in the 1st year post-diagnosis, and
the 5-year survival rate is only 8% despite treatment. During
the past 30 years, multiple investigators have demonstrated
that the incidence of adenocarcinoma of the esophagus
(ADENO) in the US and Europe has signiﬁcantly increased
compared with squamous cell carcinoma of the esophagus
(SCCA)[1–11].Thisincreasehasbeenobservedprimarilyin
non-Hispanic white males and in those of higher socioeco-
nomic status [1–3, 8, 9]. It is well accepted that chronic
gastroesophageal reﬂux disease and Barrett’s esophagus are
conditions associated with the increasing incidence of
ADENO [10–15]. Other data indicate that Arizona non-
Hispanic whites and Hispanic Americans have the same
prevalence of Barrett’s esophagus [16].
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graphical regions of the US and the world, speciﬁc data on
minority groups are indispensable in documenting whether
epidemiological changes in esophageal cancer can be
generalized. Multiple studies have conﬁrmed that adeno-
carcinoma and Barrett’s esophagus are uncommon among
African Americans [3, 17–22]. Recently, Hispanic Ameri-
cans have been similarly evaluated for esophageal cancer
[18–21]. However, only one study has assessed esophageal
cancer in Hispanic Americans for a period longer than
7 years [18].
The population of New Mexico is a diverse multiethnic
group with four distinct groups: 45% non-Hispanic white,
42% Hispanic, 10% Native American and 3% African
American or other per the 2000 US census [23]. Data on
esophageal cancer statewide are maintained in a single
database. We retrospectively evaluated the incidence of
esophageal cancer in New Mexico over a 30-year period in
order to assess any continued change in incidence and to
further evaluate the effect of ethnicity on esophageal can-
cer histology.
Methods
We retrospectively reviewed the New Mexico Tumor
Registry to obtain all cases of esophageal carcinoma
reported between 1973 and 2002. The New Mexico Tumor
Registry identiﬁes cancer cases through active surveillance
of different medical information sources, including hospital
records, outpatient clinic records, pathology and autopsy
reports, death records and radiation therapy records. Once
identiﬁed, information is collected on patient demographics
and cancer characteristics and entered into a centralized
database, which is part of the SEER (Surveillance, Epide-
miology and End Results) cancer incidence database. The
tumor registry database was reviewed for individual patient
inclusion into the study. Inclusion criteria were self-
reported ethnicity as non-Hispanic white, Hispanic Amer-
ican, Native American or African American and histologic
diagnosis of ADENO or SCCA of the esophagus. Indi-
vidual case information was gathered from the tumor reg-
istry abstract using a structured data abstraction protocol
created prior to data collection. Clinical information
included age at diagnosis, year of diagnosis and gender.
Cases were placed into 6 5-year time intervals for analysis:
1973–1977, 1978–1982, 1983–1987, 1988–1992, 1993–1997
and 1998–2002.
The overall and race-speciﬁc incidence rates were
adjusted using the direct standardization method to reﬂect
the age distribution of the 2000 US population. Incidence
rates for the 5-year periods were expressed as proportional
rates per 100,000 individuals. Incidence rates of squamous
cell carcinoma and adenocarcinoma of the esophagus
within different ethnic groups for 5-year periods were
compared using Fisher’s exact test. A result was considered
statistically signiﬁcant if P\0.05.
Results
A total of 1,168 patients with esophageal cancer were
reported in New Mexico during the 30-year study period
according to the tumor registry. One hundred eighty
patients were excluded for the following reasons: histology
not speciﬁed or histology other then ADENO or SCCA,
and ethnicity other than non-Hispanic white, African,
Hispanic or Native American. The remaining 988 patients
met inclusion criteria and comprised the study group.
Demographic data are shown in Tables 1 and 2. Patient
age ranged from 32 to 95 years. Of 988 cases of esophageal
cancer, 527 (53%) were SCCA, and 461 (47%) were
ADENO. Males represented 74% of the overall study
group, 68% of the SCCA cases and 85% of the ADENO
cases. Ethnic breakdown was as follows: non-Hispanic
white 70%, Hispanic Americans 23%, African Americans
4% and Native Americans 3%. There was no statistically
signiﬁcant difference in ethnic breakdown between those
included and excluded from the investigation.
The incidence rates of esophageal cancer per 100,000
are seen in Figs. 1 and 2. ADENO of the esophagus
Table 1 Esophageal cancer characteristics in New Mexico, 1973–
2002
Esophageal cancer cases
Total SCCA ADENO
All ethnic groups (N) 988 527 461
Non-Hispanic white N (%) 707 (71.6) 329 (62.4) 378 (82)
Hispanic American N (%) 223 (22.6) 147 (27.9) 76 (16.5)
African–American N (%) 32 (3.2) 29 (5.5) 3 (0.7)
Native-American N (%) 26 (2.6) 22 (4.2) 4 (0.8)
Table 2 Gender and histology distribution of esophageal cancer in
New Mexico from 1973–2002
Squamous cell carcinoma Adenocarcinoma
Male Female Male Female
All ethnic groups 355 172 402 59
Non-Hispanic white 201 128 328 50
Hispanic-American 114 33 69 7
African–American 21 8 2 1
Native-American 19 3 3 1
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123increased signiﬁcantly over the 30-year period: 1973–1977,
0.4 cases per 100,000 population; 1978–1982, 0.4 cases per
100,000; 1983–1987, 0.6 cases per 100,000; 1988–1992,
1.2 cases per 100,000, 1992–1997, 1.6 cases per 100,000;
1998–2002, 2.2 cases per 100,000 (P\0.001). In
comparison, the incidence of SCCA per 100,000 popula-
tion did not increase or decrease signiﬁcantly over the
study period: 1973–1977, 1.2 cases; 1978–1982, 1.5 cases;
1983–1987, 1.7 cases; 1988–1992, 1.6 cases; 1993–1997,
1.4 cases; 1998–2002, 1.1 cases.
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Fig. 1 Total population and ethnic incidence rates of esophageal
adenocarcinoma in New Mexico. Total cases of the esophageal
adenocarcinoma increased signiﬁcantly over the 30-year period:
1973–1977, 0.4 cases per 100,000; 1978–1982, 0.4 cases per 100,000;
1983–1987, 0.6 cases per 100,000; 1988–1992, 1.2 cases per 100,000;
1992–1997, 1.6 cases per 100,000; 1998–2002, 2.2 cases per 100,000
(P\0.001). Incidence rates increased over time in the non-Hispanic
white, Hispanic and Native American populations. The increase seen
in non-Hispanic whites and Hispanic Americans achieved statistical
signiﬁcance (P\0.001 for both groups)
Squamous Cell Carcinoma
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Fig. 2 Total and ethnic incidence rates of esophageal squamous cell carcinoma in New Mexico. Incidence rates did not vary signiﬁcantly among
the total population or between ethnic groups over time
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123Time trends in the incidence of esophageal cancer by
histology and ethnicity are also illustrated in Figs. 1 and 2.
In the non-Hispanic white population, the incidence of
ADENO increased signiﬁcantly over the investigation:
1973–1977, 0.4 cases per 100,000; 1978–1982, 0.6 cases
per 100,000; 1983–1987, 0.8 cases per 100,000; 1988–
1992, 1.6 cases per 100,000; 1993–1997, 2 cases per
100,000; 1998–2002, 3 cases per 100,000 (P\0.001,
Fig. 1). Also, the predominant histologic type seen in non-
Hispanic whites changed over the study period. During the
four periods between 1973 and 1992, SCCA was the pre-
vailing tumor histology. However, during the 1993–1997
and 1998–2002 periods, ADENO became the prevailing
histology seen, and this change was statistically signiﬁcant
(P\0.001, Fig. 1 and 2). In Hispanics, a signiﬁcant
increase in incidence rate for ADENO was seen during the
1993–1997 and 1998–2002 intervals in comparison to all
others: 1973–1977, 0.3 cases per 100,000; 1978–1982, 0.2
cases per 100,000; 1983–1987, 0.5 cases per 100,000;
1988–1992, 0.3 cases per 100,000; 1993–1997, 1.1 cases
per 100,000; 1998–2002, 1.2 cases per 100,000
(P\0.001, Fig. 1). Among all minorities, SCCA remained
the predominant histologic type during all study periods
(Fig. 2). Therefore, in New Mexico, the incidence of
ADENO increased during the 30-year period, and this
increase occurred primarily in non-Hispanic whites and to
a lesser extent in Hispanics.
Discussion
Esophageal cancer continues to be one of the most lethal
diseases in the US with limited survival and high mortality
[1]. During the past 30 years, the incidence of esophageal
ADENO has increased in comparison to SCCA, and this
has occurred predominantly among non-Hispanic white
males [1–9, 17–21]. Our study supports the present litera-
ture indicating that ADENO is rapidly increasing in non-
Hispanic whites, that it is increasing to a lesser degree in
Hispanic Americans and that SCCA continues to be the
primary type seen among African Americans, Hispanic
Americans and Native Americans.
The present investigation is important since it continues
to conﬁrm a role for ethnicity as a determining factor in
esophageal cancer within speciﬁc populations. In multiple
investigations to date, esophageal adenocarcinoma is pre-
dominantly seen in non-Hispanic whites, SCCA remains
predominant in African Americans, and a signiﬁcant
increase of esophageal adenocarcinoma in Hispanic
Americans has been noted [3, 9, 17–21]. The present study
indicates a protracted increase in esophageal adenocarci-
noma incidence rate among both non-Hispanic whites and
Hispanic Americans.
The demographic results of our study have both simi-
larities and differences in comparison to the previous
investigations due to the nature of the New Mexico pop-
ulation. The total number of cases observed is similar to
previous work [3]. However, the ethnic breakdown of the
minority population evaluated here, especially the Hispanic
and Native American groups, has only been reported in one
previous study [18]. The histologic variations noted are
consistent with prior studies indicating an increased pro-
portion of non-Hispanic whites with adenocarcinoma and
other ethnic groups with squamous cell carcinoma pre-
dominating. This investigation has also conﬁrmed a
recently recognized occurrence: the increase of esophageal
adenocarcinoma in the Hispanic American population [18,
19, 21, 22]. However, both the prolonged rise of adeno-
carcinoma incidence within Hispanic Americans and the
decreased incidence of SCCA among African Americans
has not been reported to date.
Barrett’s esophagus is an accepted risk factor for
esophageal adenocarcinoma, but has been documented
infrequently in minority groups [3, 16, 17, 22]. Among
Hispanics, such information is only available in two
investigations [16, 22]. In one study, Bersentes et al. [16]
reported that there was no difference in the prevalence of
Barrett’s esophagus between non-Hispanic whites and
Hispanics with or without gastroesophageal reﬂux disease
seen at the Veterans Affairs Medical Center in Tucson, AZ.
Recently, Abrams and associates noted Hispanics from the
New York City area had a decreased prevalence of Bar-
rett’s esophagus at endoscopy [22]. Unfortunately, the New
Mexico tumor registry database does not provide infor-
mation regarding the presence or absence of Barrett’s
esophagus in the cases evaluated by the present
investigation.
There are potential limitations to using the New Mexico
tumor registry as a data source. First, the presence or
absence of Barrett’s esophagus was not reported. Second,
no speciﬁc information pertaining to risk factors such as
smoking, alcohol use, obesity or frequency of gastro-
esophageal reﬂux disease was available. In addition, the
database may be subject to errors in reporting and entering
patient information.
In contrast, there are strengths to the present investiga-
tion. The New Mexico tumor registry is part of the SEER
cancer incidence database used for reporting cancer trends
within the US. The catchment area for the New Mexico
registry represents all areas of the state with a bias toward
urban regions. Demonstration of opposing ethnic trends in
different histologic types of esophageal cancer in the same
population confers internal validity to the study results.
In summary, the recently reported changes in the inci-
dence of esophageal adenocarcinoma and squamous cell
carcinoma have been conﬁrmed in the New Mexico
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123population. Also, the previously noted signiﬁcant increase
in adenocarcinoma cases among Hispanic Americans of
New Mexico from 1992–1997 has continued during the
1998–2002 period. As well, a decreased rate of SCCA
among African Americans has been observed. The reasons
for the predisposition of African, Hispanic and Native
Americans developing squamous cell cancer of the
esophagus, decreasing incidence of SCCA among African
Americans along with the continued increase of adeno-
carcinoma incidence among New Mexico Hispanic
Americans is not presently known. This suggests that eth-
nicity may inﬂuence esophageal cancer histology or that
ethnic background can place an individual at increased risk
for certain types of esophageal cancer. Notwithstanding,
ethnicity either directly inﬂuences the type of esophageal
cancer in Americans or may represent a surrogate marker
for an as yet undeﬁned risk factor in esophageal cancer.
Further investigation and ethnic-speciﬁc research and
education are needed to completely understand esophageal
cancer in New Mexico and the US.
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